NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE126463 Query DataSets for GSE126463
Status Public on Jul 22, 2020
Title mRNA-sequencing for MM.1S cells that were treated with pomalidomide or were expressing shRNA against ARID2 or Aiolos.
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary To dissect the roles of ARID2 and Aiolos in pomalidomide-induced transcriptional changes, we performed mRNA-sequencing of MM.1S cells expressing shRNA against ARID2 or Aiolos and compared them with MM.1S cells that were treated with pomalidomide for 24, 48, or 72 hours.
 
Overall design We performed mRNA-sequencing for MM.1S cells that were treated with 1 ┬ÁM pomalidomide for 0, 24, 48, or 72 hours or were expressing shRNA against ARID2 or Aiolos for 72 hours (7 conditions with 3 biological replicates). Sequencing was done on the NovaSeq 6000 system (Illumina).
 
Contributor(s) Yamamoto J, Yamaguchi Y
Citation(s) 32958952
Submission date Feb 12, 2019
Last update date Oct 21, 2020
Contact name Yuki Yamaguchi
E-mail(s) yyamaguc@bio.titech.ac.jp
Organization name Tokyo Institute of Technology
Department School of Life Science and Technology
Street address Nagatsutacho 4259
City Yokohama
ZIP/Postal code 226-8501
Country Japan
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (21)
GSM3602132 Non-treat-1
GSM3602133 Non-treat-2
GSM3602134 Non-treat-3
Relations
BioProject PRJNA521983
SRA SRP185722

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE126463_190209_yamamoto_RNA-seq_TPM.txt.gz 1.8 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap